Literature DB >> 29709712

Underdiagnoses resulting from variant misinterpretation: Time for systematic reanalysis of whole exome data?

Fathiya Al-Murshedi1, Douja Meftah1, Patrick Scott2.   

Abstract

BACKGROUND: Clinical whole exome sequencing (WES) yields a diagnosis in approximately 30% of patients evaluated for presumed genetic disorders. For unsolved cases, periodic reanalysis is usually predicated on the availability of improved bioinformatics tools or new gene discoveries.
METHODS: Exome data reanalysis was independently performed on unsolved cases that had underwent trio analysis by an external service provider. The retrieved exome data was reannotated using wANNOVAR and reanalysed following standard filtering criteria.
RESULTS: Independent reanalysis led to the identification of a disease-causing variation in two families segregating predominantly a neurological phenotype. As the causative genes were relatively well established at the time the WES referral was made, misinterpretation of the functional impact of the variant and/or underappreciation of the gene's associated phenotype are the most probable causes of the discrepancy in reporting.
CONCLUSION: Non-diagnostic clinical exome resulting from variant misinterpretation is probably under appreciated. These results emphasise the relevance of implement a policy for the reanalysis of high-throughput sequencing data, especially in a clinical context given the implications.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Diagnostic yield; Unsolved exomes; Variation assessment

Mesh:

Substances:

Year:  2018        PMID: 29709712     DOI: 10.1016/j.ejmg.2018.04.016

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  3 in total

1.  The Responsibility to Recontact Research Participants after Reinterpretation of Genetic and Genomic Research Results.

Authors:  Yvonne Bombard; Kyle B Brothers; Sara Fitzgerald-Butt; Nanibaa' A Garrison; Leila Jamal; Cynthia A James; Gail P Jarvik; Jennifer B McCormick; Tanya N Nelson; Kelly E Ormond; Heidi L Rehm; Julie Richer; Emmanuelle Souzeau; Jason L Vassy; Jennifer K Wagner; Howard P Levy
Journal:  Am J Hum Genet       Date:  2019-04-04       Impact factor: 11.025

2.  Targeted RNAseq Improves Clinical Diagnosis of Very Early-Onset Pediatric Immune Dysregulation.

Authors:  Kiera Berger; Dalia Arafat; Shanmuganathan Chandrakasan; Scott B Snapper; Greg Gibson
Journal:  J Pers Med       Date:  2022-06-01

Review 3.  Clinical Exome Reanalysis: Current Practice and Beyond.

Authors:  Jianling Ji; Marco L Leung; Samuel Baker; Joshua L Deignan; Avni Santani
Journal:  Mol Diagn Ther       Date:  2021-07-20       Impact factor: 4.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.